Lower Extremity

7

Review clinical trials related to Lower Extremity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Negative Pressure Wound Therapy for Split Thickness Skin Grafting to the Lower Leg After Excision of Skin Tumour: A Multicentre Randomised Study

The goal of this clinical trial is to compare the effect of negative pressure wound therapy (NPWT) versus traditional dressings on the incidence of transplant infection in adult patients undergoing split-thickness skin grafting (STSG) to the lower leg following excision of a skin tumour. The main questions it aims to answer are: Does NPWT reduce the incidence of transplant infection within three months after STSG? Does NPWT improve secondary outcomes such as graft take, reduce reoperations, complications, and resource use? Researchers will compare patients treated with NPWT to patients treated with traditional dressings to see if NPWT results in lower infection rates and better clinical outcomes. Participants will: Undergo excision of a skin tumour on the lower leg followed by STSG. Be randomized to receive either NPWT or traditional dressings applied over the graft. Follow a structured postoperative care and mobilisation schedule. Attend follow-up visits at day 5 and day 14 postoperatively and be monitored through medical record review up to three months after surgery.

Participants needed: 242
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Region SkaneUpdated: May 28, 2026Locations: 1
Eligibility criteria

Adults aged 18 years or older [+4]

Inability to follow postoperative instructions due to cognitive impairment, deme... [+14]

Status: Recruiting

Bupivacaine-Lidocaine vs Bupivacaine for Ultrasound-Guided Popliteal Sciatic Nerve Block

This prospective, randomized, double-blind clinical trial aims to compare the efficacy of two local anesthetic regimens for ultrasound-guided popliteal sciatic nerve block in adult patients undergoing elective distal lower extremity surgery. Eligible participants (ages 18-65, ASA physical status I-III, BMI 18-35 kg/m²) will be randomized into two equal groups of 30. Patients in Group BL will receive a combination of 10 mL 2% lidocaine and 10 mL 0.5% bupivacaine, while patients in Group B will receive 20 mL 0.5% bupivacaine alone, administered via ultrasound-guided popliteal sciatic nerve block prior to surgery. The primary outcome is the onset time of sensory and motor blockade. Secondary outcomes include block success rate, duration of sensory and motor block, postoperative opioid consumption, pain scores assessed by the Numeric Rating Scale (NRS) at 2, 4, 8, 12, and 24 hours postoperatively, Quality of Recovery-15 (QoR-15) score, and incidence of rebound pain. The study is conducted at Ataturk University Research Hospital, Department of Anesthesiology and Reanimation, Erzurum, Turkey.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Ataturk UniversityUpdated: May 12, 2026Locations: 1
Eligibility criteria

Age between 18 and 65 years [+4]

Refusal to participate in the study [+8]

Status: Recruiting

Photoacoustic Tomography in Assessment of Lower Extremity Artery Disease

Lower extremity artery disease (LEAD) is characterized by low awareness rate and high missed diagnosis rate, leading to low treatment rate and high disabling mortality rate. However, none of the current examination methods can comprehensively and thoroughly evaluate the vascular structure and blood oxygen status of the lower extremity at the same time. Photoacoustic imaging can display millimeter-scale microvessels without the need for contrast agents. The investigators developed photoacoustic tomography (PACT) technology, which wass able to provide three-dimensional and high-resolution photoacoustic images of the target area.The investigators plan to recruit LEAD patients in different disease conditions and healthy volunteers to receive the PACT examination on the feet using this imaging system, and to evaluate the potential clinical role of the imaging system in LEAD, and its added value to current imaging methods.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Sun Yat-sen UniversityUpdated: May 6, 2026Locations: 1
Eligibility criteria

Inclusion of the case group 1) LEAD patients; 2) Patients voluntarily take part... [+1]

age <18 years; [+4]

Status: Recruiting

Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers

This study will evaluate Matrion™ (LifeNet Health, Inc., Virginia Beach, VA), a placental membrane product, as a treatment for diabetic foot ulcers compared to conventional wound care. Matrion is derived from donated human birth tissue and includes both the amniotic and chorionic layers, along with the trophoblast layer. It is minimally processed using a proprietary decellularization method and terminally sterilized to ensure the membrane is acellular and sterile, making it suitable for surgical applications.

Participants needed: 120
Trial details
Age: 21-80Biological sex: AllType: InterventionalSponsor: LifeNet HealthUpdated: Dec 10, 2025Locations: 18
Eligibility criteria

Be male or female and aged between 21 and 80 years at the time of informed conse... [+14]

Be pregnant or lactating [+19]

Status: Recruiting

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

The current work evaluated whether the combination of intrathecal dexmedetomidine and fentanyl provides superior postoperative analgesia to fentanyl alone when administered with hyperbaric bupivacaine.

Participants needed: 58
Trial details
Age: 18-60Biological sex: AllType: InterventionalSponsor: National Cancer Institute, EgyptUpdated: Dec 11, 2025Locations: 1
Eligibility criteria

Age from 18 to 60 years. [+5]

Allergy to any of the investigated drugs. [+4]

Status: Recruiting

C-Brace Prospective Registry

To gather prospective safety and effectiveness data for the C-Brace System following the standard of care.

Participants needed: 250
Trial details
Biological sex: AllType: ObservationalSponsor: Otto Bock Healthcare Products GmbHUpdated: Apr 30, 2025Locations: 76Duration: 12 Months
Eligibility criteria

Patient has been evaluated and successfully tested with the Trial Tool, and has... [+2]

Patient is geographically inaccessible to comply and participate in the registry... [+1]

Status: Not yet recruiting

Foot Biomechanics and Lower Extremity Muscle Mechanics

This study is designed to investigate the relationship between foot biomechanics, balance, lower extremity muscle mechanical properties, and vertical jump in young adults. The aim is to highlight the correlations between foot biomechanics and the other parameters, as well as potential outcomes (if any).

Participants needed: 56
Trial details
Age: 18-25Biological sex: AllType: ObservationalSponsor: Bandırma Onyedi Eylül UniversityUpdated: Mar 4, 2025Locations: 1Duration: 1 Day
Eligibility criteria

Willing to participate in the study [+2]

Having a physical disability that prevents participation in the study (e.g., use... [+2]